Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic

Detalles Bibliográficos
Autores principales: Imaduddin, Mohammed, Sultania, Mahesh, Vigneshwaran, B., Muduly, Dillip Kumar, Kar, Madhabananda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584917/
https://www.ncbi.nlm.nih.gov/pubmed/33144057
http://dx.doi.org/10.1016/j.oraloncology.2020.105069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584917/
https://www.ncbi.nlm.nih.gov/pubmed/33144057
http://dx.doi.org/10.1016/j.oraloncology.2020.105069

Ejemplares similares